| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.44B | -8.0% |
| R&D Expense | $42.0M | -30.0% |
| SG&A Expense | $322.2M | -14.2% |
| Operating Income | -$1.60B | -840.0% |
| Interest Expense | $102.2M | +3.5% |
| Pre-tax Income | -$1.68B | -566.9% |
| Income Tax | -$398.9M | -1068.1% |
| Net Income | -$1.28B | -488.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.8M | -41.8% |
| Inventory | $182.4M | +20.8% |
| Current Assets | $747.4M | +0.7% |
| Total Assets | $2.00B | -42.5% |
| Current Liabilities | $2.04B | +362.6% |
| Long-term Debt | $1.54B | -0.5% |
| Total Liabilities | $2.85B | -7.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $56.8M | +122.9% |
| Capital Expenditures | $114.4M | -44.3% |
| Investing Cash Flow | -$135.4M | -164.6% |
| Financing Cash Flow | -$8.2M | +99.2% |
| Free Cash Flow | -$57.6M | +87.3% |
| Stockholders' Equity |
| -$896.5M |
| -364.9% |